{"transactions":[{"id":3843500,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":164313,"kind":"organization","name":"Antibody Investments LLC","position":1,"cik":"0001749340","reported_name":"Antibody Investments LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164314,"kind":"person","name":"Shumacher Michael","position":2,"cik":"0001749366","reported_name":"Shumacher Michael","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series D Convertible Preferred Stock","published_at":"2018-08-15T16:49:46.000Z","date":"2018-08-13","kind":"exercise","acquired":false,"shares":5494505,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The reported securities converted into shares of Common Stock on a 1-for-10 basis immediately prior to the consummation of the Issuer's initial public offering."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported securities converted into shares of Common Stock on a 1-for-10 basis immediately prior to the consummation of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The reported securities converted into shares of Common Stock on a 1-for-10 basis immediately prior to the consummation of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The reported securities converted into shares of Common Stock on a 1-for-10 basis immediately prior to the consummation of the Issuer's initial public offering."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":549444},"source":{"system":"sec-edgar","filing":"0001123292-18-000927","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1749340/000112329218000927/edgar.xml","form_type":"4"}},{"id":3843499,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":164313,"kind":"organization","name":"Antibody Investments LLC","position":1,"cik":"0001749340","reported_name":"Antibody Investments LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164314,"kind":"person","name":"Shumacher Michael","position":2,"cik":"0001749366","reported_name":"Shumacher Michael","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Convertible Preferred Stock","published_at":"2018-08-15T16:49:46.000Z","date":"2018-08-13","kind":"exercise","acquired":false,"shares":7205882,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The reported securities converted into shares of Common Stock on a 0.1868-for-1 basis immediately prior to the consummation of the Issuer's initial public offering."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities converted into shares of Common Stock on a 0.1868-for-1 basis immediately prior to the consummation of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reported securities converted into shares of Common Stock on a 0.1868-for-1 basis immediately prior to the consummation of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The reported securities converted into shares of Common Stock on a 0.1868-for-1 basis immediately prior to the consummation of the Issuer's initial public offering."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1346139},"source":{"system":"sec-edgar","filing":"0001123292-18-000927","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1749340/000112329218000927/edgar.xml","form_type":"4"}},{"id":3843498,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":164313,"kind":"organization","name":"Antibody Investments LLC","position":1,"cik":"0001749340","reported_name":"Antibody Investments LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164314,"kind":"person","name":"Shumacher Michael","position":2,"cik":"0001749366","reported_name":"Shumacher Michael","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-08-15T16:49:46.000Z","date":"2018-08-13","kind":"exercise","acquired":true,"shares":549444,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported securities converted into shares of Common Stock on a 1-for-10 basis immediately prior to the consummation of the Issuer's initial public offering."}],"balance_after":1895583,"source":{"system":"sec-edgar","filing":"0001123292-18-000927","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1749340/000112329218000927/edgar.xml","form_type":"4"}},{"id":3843497,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":164313,"kind":"organization","name":"Antibody Investments LLC","position":1,"cik":"0001749340","reported_name":"Antibody Investments LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164314,"kind":"person","name":"Shumacher Michael","position":2,"cik":"0001749366","reported_name":"Shumacher Michael","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-08-15T16:49:46.000Z","date":"2018-08-13","kind":"exercise","acquired":true,"shares":1346139,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities converted into shares of Common Stock on a 0.1868-for-1 basis immediately prior to the consummation of the Issuer's initial public offering."}],"balance_after":1346139,"source":{"system":"sec-edgar","filing":"0001123292-18-000927","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1749340/000112329218000927/edgar.xml","form_type":"4"}}]}